Hi disas---------------part yours :-
'...............and given the clinical results so far, it does seem to outperform the competitors products. YEs, it will be tough to take market share from the well established competitors, but the product may just sell it self. remembering that every year of trials and early days of standard use, there will be a new cohort of trainee physicians who wont be as difficult to convince to chose AVR over the other.'
I have had this 'mind image' for some time.. USA of course.
As time passes and our product gets the 'snowball effect':-
Patient---- needs urgent heart valve replacement . Advises Dr 'I want the top of the range valve'
Dr----Uses one of the competitors..
Patient--- some time after then replacement finds that the valve - was not the 'top of the range' Starts to do some in depth research -with his Lawyer.
Use your imagination on the outcome, remembering -it is in the USA whose residents are born with some form of 'litigious ???' (my description )
In my opinion Doctors are becoming aware of our product................ have a look at those attending the seminars etc... we have.
Keep safe - pain before gain ?
- Forums
- ASX - By Stock
- AVR
- I'm done.!!!!
I'm done.!!!!, page-50
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.14 |
Change
0.000(0.00%) |
Mkt cap ! $277.7M |
Open | High | Low | Value | Volume |
$13.33 | $13.91 | $13.14 | $302.2K | 22.46K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 299 | $13.14 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.49 | 35 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 299 | 13.140 |
4 | 2791 | 13.000 |
2 | 67 | 12.900 |
1 | 1000 | 12.500 |
1 | 1500 | 11.610 |
Price($) | Vol. | No. |
---|---|---|
13.490 | 35 | 1 |
13.500 | 750 | 1 |
14.100 | 100 | 1 |
14.440 | 25 | 1 |
14.500 | 60 | 1 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online